MiMedx Group (MDXG)
(Delayed Data from NSDQ)
$7.02 USD
-0.13 (-1.82%)
Updated Sep 19, 2025 04:00 PM ET
After-Market: $7.02 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
B Value A Growth B Momentum A VGM
Fundamental Charts
About Price to Cash Flow
The Price to Cash Flow ratio or P/CF is price divided by its cash flow per share. It's another great way to determine whether a company is undervalued or overvalued with the denominator being cash flow. One of the reasons why some investors prefer the P/CF ratio over the P/E ratio is because the net income of the cash flow portion rightly adds depreciation and amortization back in since these are not cash expenditures. In contrast, the net income that goes into the earnings portion of the P/E ratio does not add these in, thus artificially reducing the income and skewing the P/E ratio. Like the P/E ratio, a lower number is considered better. A value under 20 is generally considered good.
MDXG 7.02 -0.13(-1.82%)
Will MDXG be a Portfolio Killer in September?
Zacks Investment Research is releasing its prediction for MDXG based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for MDXG
MiMedx (MDXG) Q2 Earnings and Revenues Beat Estimates
Strength Seen in MiMedx (MDXG): Can Its 8.0% Jump Turn into More Strength?
MDXG: What are Zacks experts saying now?
Zacks Private Portfolio Services
MiMedx (MDXG) Q1 Earnings Match Estimates
BioHarvest Sciences Inc. (BHST) Reports Q4 Loss, Lags Revenue Estimates
Strength Seen in Sarepta Therapeutics (SRPT): Can Its 8.7% Jump Turn into More Strength?
Other News for MDXG
Is MDXG building bearish momentum? Fell Below 20 Day Moving Average shows up after declining 1.82%
Crossed Above 20 Day Moving Average appears for MDXG after 3.03% move
Directional Movement Crossover Bullish appears for MDXG after 0.43% move
Is MDXG heading for a slide? 50 Day Moving Average Resistance shows up after a flat session
Is MDXG preparing to trend lower? 50 Day Moving Average Resistance shows up after rising 0.43%